Epigenetic inactivation of secreted frizzled-related protein 2 in esophageal squamous cell carcinoma
- PMID: 22363119
- PMCID: PMC3280398
- DOI: 10.3748/wjg.v18.i6.532
Epigenetic inactivation of secreted frizzled-related protein 2 in esophageal squamous cell carcinoma
Abstract
Aim: To investigate the expression and methylation status of the secreted frizzled-related protein 2 (SFRP2) in esophageal squamous cell carcinoma (ESCC) and explore its role in ESCC carcinogenesis.
Methods: Seven ESCC cell lines (KYSE 30, KYSE150, KYSE410, KYSE510, EC109, EC9706 and TE-1) and one immortalized human esophageal epithelial cell line (Het-1A), 20 ESCC tissue samples and 20 paired adjacent non-tumor esophageal epithelial tissues were analyzed in this study. Reverse-transcription polymerase chain reaction (RT-PCR) was employed to investigate the expression of SFRP2 in cell lines, primary ESCC tumor tissue, and paired adjacent normal tissue. Methylation status was evaluated by methylation-specific PCR and bisulfite sequencing. The correlation between expression and promoter methylation of the SFRP2 gene was confirmed with treatment of 5-aza-2'-deoxycytidine. To assess the potential role of SFRP2 in ESCC, we established stable SFRP2-transfected cells and examined them with regard to cell proliferation, colony formation, apoptosis and cell cycle in vivo and in vitro.
Results: SFRP2 mRNA was expressed in the immortalized normal esophageal epithelial cell line but not in seven ESCC cell lines. By methylation-specific PCR, complete methylation was detected in three cell lines with silenced SFRP2 expression, and extensive methylation was observed in the other four ESCC cell lines. 5-aza-2'-deoxycytidine could restore the expression of SFRP2 mRNA in the three ESCC cell lines lacking SFRP2 expression. SFRP2 mRNA expression was obviously lower in primary ESCC tissue than in adjacent normal tissue (0.939 ± 0.398 vs 1.51 ± 0.399, P < 0.01). SFRP2 methylation was higher in tumor tissue than in paired normal tissue (95% vs 65%, P < 0.05). The DNA methylation status of the SFRP2 correlated inversely with the SFRP2 expression. To assess the potential role of SFRP2 in ESCC, we established stable SFRP2 transfectants and control counterparts by introducing pcDNA3.1/v5 hisA -SFRP2 or pcDNA3.1/v5 hisA -empty vector into KYSE30 cells lacking SFRP2 expression. After transfection, the forced-expression of SFRP2 was confirmed by the RT-PCR. In comparison with the control groups, stably-expressed SFRP2 in KYSE 30 cells significantly reduced colony formation in vitro (47.17% ± 15.61% vs 17% ± 3.6%, P = 0.031) and tumor growth in nude mice (917.86 ± 249.35 mm(3)vs 337.23 ± 124.43 mm(3), P < 0.05). Using flow cytometry analysis, we found a significantly higher number of early apoptotic cells in SFRP2-transfected cells than in the control cells (P = 0.025). The mean cell number in the S and G2-M phases of the cell cycle was also significantly lower in SFRP2-transfected KYSE30 cells compared with mock transfected counterparts.
Conclusion: Silencing of SFRP2 expression through promoter hypermethylation may be a factor in ESCC carcinogenesis through loss of its tumor-suppressive activity.
Keywords: Esophageal squamous cell carcinoma; Methylation; Secreted frizzled-related protein 2; Tumor suppressor gene; Wnt signaling pathway.
Figures







Similar articles
-
Epigenetic inactivation of the SFRP1 gene in esophageal squamous cell carcinoma.Dig Dis Sci. 2011 Nov;56(11):3195-203. doi: 10.1007/s10620-011-1734-7. Epub 2011 May 13. Dig Dis Sci. 2011. PMID: 21567192
-
Decreased expression of retinoblastoma protein-interacting zinc-finger gene 1 in human esophageal squamous cell cancer by DNA methylation.Clin Lab. 2012;58(1-2):41-51. Clin Lab. 2012. PMID: 22372344
-
Identification of GPX3 epigenetically silenced by CpG methylation in human esophageal squamous cell carcinoma.Dig Dis Sci. 2011 Mar;56(3):681-8. doi: 10.1007/s10620-010-1369-0. Epub 2010 Aug 20. Dig Dis Sci. 2011. PMID: 20725785
-
The detective, prognostic, and predictive value of DNA methylation in human esophageal squamous cell carcinoma.Clin Epigenetics. 2016 Apr 22;8:43. doi: 10.1186/s13148-016-0210-9. eCollection 2016. Clin Epigenetics. 2016. PMID: 27110300 Free PMC article. Review.
-
Promoter methylation of tumor suppressor genes in esophageal squamous cell carcinoma.Chin J Cancer. 2013 Jan;32(1):3-11. doi: 10.5732/cjc.011.10381. Epub 2012 May 8. Chin J Cancer. 2013. PMID: 22572016 Free PMC article. Review.
Cited by
-
Molecular alterations and clinical relevance in esophageal squamous cell carcinoma.Front Med. 2013 Dec;7(4):401-10. doi: 10.1007/s11684-013-0286-y. Epub 2013 Sep 3. Front Med. 2013. PMID: 24002746 Review.
-
Clinicopathological significance of wnt/β-catenin signaling pathway in esophageal squamous cell carcinoma.Int J Clin Exp Pathol. 2015 Mar 1;8(3):3045-53. eCollection 2015. Int J Clin Exp Pathol. 2015. PMID: 26045816 Free PMC article.
-
Prediction of recurrence free survival for esophageal cancer patients using a protein signature based risk model.Oncotarget. 2022 Sep 14;13:1020-1032. doi: 10.18632/oncotarget.10656. eCollection 2022. Oncotarget. 2022. PMID: 36128326 Free PMC article.
-
Downregulation of RIKP by miR-200a promotes the invasive ability of esophageal cancer cells by upregulating the expression of LIN28 and MMP-14.Int J Clin Exp Pathol. 2017 Aug 1;10(8):8452-8460. eCollection 2017. Int J Clin Exp Pathol. 2017. Retraction in: Int J Clin Exp Pathol. 2021 Jul 15;14(7):857. PMID: 31966697 Free PMC article. Retracted.
-
The Silencing of SFRP2 Expression in ESCC Is Due to Methylation of the Gene Promoter.Technol Cancer Res Treat. 2019 Jan 1;18:1533033819877977. doi: 10.1177/1533033819877977. Technol Cancer Res Treat. 2019. PMID: 31578133 Free PMC article.
References
-
- Enzinger PC, Mayer RJ. Esophageal cancer. N Engl J Med. 2003;349:2241–2252. - PubMed
-
- Tamoto E, Tada M, Murakawa K, Takada M, Shindo G, Teramoto K, Matsunaga A, Komuro K, Kanai M, Kawakami A, et al. Gene-expression profile changes correlated with tumor progression and lymph node metastasis in esophageal cancer. Clin Cancer Res. 2004;10:3629–3638. - PubMed
-
- Esteller M. Epigenetics in cancer. N Engl J Med. 2008;358:1148–1159. - PubMed
-
- Feng Q, Balasubramanian A, Hawes SE, Toure P, Sow PS, Dem A, Dembele B, Critchlow CW, Xi L, Lu H, et al. Detection of hypermethylated genes in women with and without cervical neoplasia. J Natl Cancer Inst. 2005;97:273–282. - PubMed
-
- Yu J, Cheng YY, Tao Q, Cheung KF, Lam CN, Geng H, Tian LW, Wong YP, Tong JH, Ying JM, et al. Methylation of protocadherin 10, a novel tumor suppressor, is associated with poor prognosis in patients with gastric cancer. Gastroenterology. 2009;136:640–51.e1. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical